Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study highlights risks of subcutaneous ureteral bypass placement
Major complications from SUB occurred in 48 per cent of the cats studied.

Researchers analyse the medical records of 95 cats fitted with SUB devices.

Subcutaneous ureteral bypass (SUB) placement is associated with a high complication rate, according to new research.

The study, published in the Journal of Small Animal Practice (JSAP), found that most of these complications are manageable, resulting in an average survival time of over two years. It also suggests that imaging techniques, such as fluoroscopy, are useful in identifying complications. 

In the study, researchers analysed the medical record of  95 cats fitted with SUBs between April 2012 and June 2017. The information recorded included imaging modality used for diagnosis, whether urethral catheterisation was performed and whether obstruction was uni- or bilateral. 

They found that minor complications - defined as infection or technical problem which resolved with none or minor treatment - occurred in 19 per cent of the cats. Major complications - defined as infection or technical problem resulting in revision surgery, removal of the SUBs or death/euthanasia – occurred in 48 per cent of the cats. Eleven per cent of cats analysed in the study did not survive to discharge. 

Dr Nicola Kulendra, lead author for the paper said: “A significant association between long-term survival and creatinine at presentation was identified. The median survival time for cats presenting with creatinine concentration ≥440 μmol/L (International Renal Interest Society stage acute kidney injury (AKI) 4 and 5) was 530 days, compared to a median survival time of 949 days for those cats presenting with creatinine <440 μmol/L (International Renal Interest Society stage AKI 1–3).”

JSAP editor Nicola Di Girolamo, concluded: “Veterinary medicine is advancing fast and it is exciting to see treatment options that just a decade ago were rarely considered are now accessible to many of our patients. Furthermore, it is excellent to see the veterinary sector is publishing articles of this nature, demonstrating the risks and complications of a procedure, to support proper discussion with owners and referring veterinarians.”

Image © BSAVA Manual of Canine and Feline Abdominal Surgery 2nd Ed.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
BSAVA publishes fifth Manual of Canine and Feline Neurology

The BSAVA has published the fifth edition of its BSAVA Manual of Canine and Feline Neurology.

The new edition has been reviewed and updated, including new developments in diagnostics, therapeutic approaches and clinical decision-making. It is structured to support clinicians through diagnosis, treatment and long-term management.

The guide features five new chapters covering acute myelopathies, chronic myelopathies, emergency protocols, neurotoxicology and neuro-oncology.

It also includes over 100 videos, including demonstrations of neurological examinations, clinical presentations and diagnostic procedures.

Nicola Lloyd, publishing manager, said: "Whether you're a general practitioner seeking practical guidance, or a specialist aiming to refine your expertise, this edition remains an indispensable reference for anyone involved in the care of neurologically compromised dogs and cats."